Plain-English translation of NCT05614310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Researchers are testing a new MRI brain scanning technique called glucoCEST that may help detect Alzheimer's disease in its early stages. Unlike current methods that use radioactive tracers, this new scan uses only magnetic resonance imaging—similar to standard MRI scans you may have had before. The goal is to create a safer, simpler way for doctors to catch Alzheimer's early, when treatment may be most helpful.
Currently, doctors diagnose Alzheimer's using a combination of memory tests, clinical exams, and brain imaging, which takes time and uses expensive equipment. This trial exists because the new scanning method could be faster, safer, and cheaper than existing options, helping more people get diagnosed and treated earlier.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll have one or two visits about a week apart. At each visit, you'll have your blood sugar checked with a quick pinprick test before and after an MRI brain scan—the same type of safe, non-radioactive scan used in routine medical care. If you're a patient with Alzheimer's, you'll also have one PET scan (a specialized imaging test) at your first visit. You'll be asked to avoid sugar and exercise for 24 hours before each visit and to skip eating for 6 hours before your scan appointment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United Kingdom